ArticleGastroenterology & hepatology2024
Phase 3 ESSENCE Trial: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
No numbers read from the abstract.
20 papers cite it
this papertrialcites it
ArticleGastroenterology & hepatology2024
No numbers read from the abstract.